Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Other Non-Current Assets (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Other Non-Current Assets for 15 consecutive years, with $5.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets rose 92.41% to $5.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.3 million, a 92.41% increase, with the full-year FY2024 number at $6.3 million, up 531.16% from a year prior.
  • Other Non-Current Assets was $5.3 million for Q3 2025 at Gyre Therapeutics, roughly flat from $5.3 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $6.3 million in Q4 2024 to a low of $168000.0 in Q2 2022.
  • A 5-year average of $1.9 million and a median of $869000.0 in 2021 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: plummeted 85.63% in 2022, then surged 1546.43% in 2024.
  • Gyre Therapeutics' Other Non-Current Assets stood at $472000.0 in 2021, then soared by 619.07% to $3.4 million in 2022, then tumbled by 70.68% to $995000.0 in 2023, then skyrocketed by 531.16% to $6.3 million in 2024, then decreased by 15.25% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Other Non-Current Assets are $5.3 million (Q3 2025), $5.3 million (Q2 2025), and $5.6 million (Q1 2025).